Clinical trial for Stress Disorders, Post-Traumatic
Official title Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication
ClinicalTrials.gov ID: NCT06088303
What this study is testing
- What it's testing
- This study aims to find out if adding a simple writing task to common PTSD treatments helps patients and therapists communicate better and leads to better outcomes.
- Who it's for
- The study is looking for adults who have been diagnosed with post-traumatic stress disorder (PTSD).
- What's involved
- Participants will receive standard PTSD therapy (either cognitive processing therapy or prolonged exposure). Some will also do a brief writing exercise about their treatment experience, while their therapist will use guided responses to discuss it.
- Time commitment
- The study involves a small initial group of four people, followed by a larger group of 50, with visits required for therapy sessions and feedback.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of PTSD
- Stable on psychiatric medications for at least 4 weeks
You likely can't join if
- Current unstable bipolar disorder
- Current psychosis
- Current active suicidal or homicidal ideation with intent or plan
- Current severe substance use that warrants immediate medical attention
- Current trauma-focused treatment
- Significant cognitive impairment that would prevent engagement in assessments and therapy (e.g., advanced dementia, severe traumatic brain injury).
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.